Product image of Linezolid Altan (Linezolid) supplied by GNH India

Linezolid Altan

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Altan (Linezolid)

Linezolid, the active ingredient in Linezolid Altan, is a oxazolidinone antibiotic presented as an intravenous formulation for injection use. It treats serious Gram‑positive bacterial infections, including those caused by methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients requiring hospital care.

GNH India supplies Linezolid Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Altan Pharmaceuticals S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to manage infections caused by resistant Gram‑positive bacteria.

  • Complicated skin and soft tissue infections: provides bacterial eradication and clinical improvement.
  • Community‑acquired bacterial pneumonia: reduces pathogen load and accelerates recovery.
  • Nosocomial pneumonia: effective against hospital‑acquired resistant strains.
  • Infections caused by methicillin‑resistant Staphylococcus aureus (MRSA): achieves rapid bacterial clearance.
  • Infections caused by vancomycin‑resistant Enterococcus (VRE): offers a therapeutic option where alternatives fail.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex required for translation. This action blocks the production of essential proteins, leading to bacteriostatic activity against susceptible Gram‑positive organisms, including resistant strains such as MRSA and VRE.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools occurring during therapy.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste perception.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Peripheral neuropathy: nerve damage causing tingling or numbness.
  • Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents.
  • Lactic acidosis: buildup of lactate leading to metabolic disturbance.
  • Optic neuropathy: vision changes requiring immediate evaluation.

Precautions & Warnings

Before initiating Linezolid therapy, consider the following safety measures.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly.
  • Concomitant serotonergic drugs: avoid to prevent serotonin syndrome.
  • Bone marrow suppression: perform routine complete blood counts.
  • Hypersensitivity: discontinue if allergic reaction occurs.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Linezolid can interact with several medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome.
  • Rifampin: may reduce linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: may increase INR and bleeding risk.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): potential for enhanced bleeding.
  • Carbamazepine and other anticonvulsants: may lower linezolid effectiveness.

Frequently Asked Questions

Linezolid Altan is indicated for serious Gram‑positive bacterial infections such as complicated skin and soft tissue infections, community‑acquired and nosocomial pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) or vancomycin‑resistant Enterococcus (VRE). It is administered in a hospital setting to patients who need intravenous therapy.

Linezolid blocks bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex required for translation. This inhibition stops the production of essential proteins, resulting in a bacteriostatic effect against susceptible Gram‑positive organisms, including resistant strains.

The dosage of Linezolid Altan is determined by the prescribing clinician based on the specific infection, patient weight, renal and hepatic function, and local treatment guidelines. Healthcare professionals set the appropriate dose and duration for each individual case.

Safety data for Linezolid during pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Linezolid offers a unique mechanism by inhibiting protein synthesis, making it effective against resistant Gram‑positive bacteria such as MRSA and VRE where many beta‑lactams fail. Compared with vancomycin, it provides oral and IV options and does not require therapeutic drug monitoring, though it carries distinct safety considerations.

Linezolid Altan should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Maintaining these conditions helps preserve the drug’s stability and potency throughout its shelf life.

Linezolid Altan is supplied as an intravenous solution and is administered by slow infusion into a vein, typically in a hospital or clinical setting. The exact infusion rate and schedule are determined by the treating physician.

Serious risks include thrombocytopenia, peripheral neuropathy, serotonin syndrome when combined with serotonergic agents, lactic acidosis, and optic neuropathy. Patients should be monitored regularly for blood count changes and neurological symptoms, and any severe reaction warrants immediate medical attention.

Linezolid Altan is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation. Caution is also advised for individuals taking serotonergic drugs, those with existing bone‑marrow suppression, or patients with uncontrolled hypertension due to potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT